EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Trends and correlates of concurrent opioid and benzodiazepine and/or gabapentinoid use among Ontario nursing home residents

David B Hogan, Michael A Campitelli, Susan E Bronskill iD, Andrea Iaboni iD, Heather E Barry, Carmel M Hughes, Sudeep S Gill, Colleen J Maxwell iD

Journal of the American Geriatrics Society · 2023

DOI: 10.1111/jgs.18320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, 2023. Verfasst von David B Hogan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Geriatric Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Analgesics, Opioid, Benzodiazepines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research, Institute for Clinical Evaluative Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A concern with long‐term opioid use is the increased risk arising when opioids are used concurrently with drugs that can potentiate their associated adverse effects. The drugs most often encountered are benzodiazepines (BZDs) and gabapentinoids. Our study objectives were to examine trends in the concurrent use of opioids and BZDs, or gabapentinoids, in a Canadian nursing home population over an 11‐year period, and current resident‐level correlates of this concurrent use.

Methods

We conducted a population‐based, repeated cross‐sectional study among Ontario nursing home residents (>65 years) dispensed opioids between April 2009 and February 2020. For the last study year, we examined cross‐sectional associations between resident characteristics and concurrent use of opioids with BZDs or gabapentinoids. Linked data on nursing home residents from clinical and health administrative databases was used. The yearly proportions of residents who were dispensed an opioid concurrently with a BZD or gabapentinoid were plotted with percent change derived from log‐binomial regression models. Separate modified Poisson regression models estimated resident‐level correlates of concurrent use of opioids with BZDs or gabapentinoids.

Results

Over the study period, among residents dispensed an opioid there was a 53.2% relative decrease (30.7% to 14.4%) in concurrent BZD and a 505.4% relative increase (4.4% to 26.6%) in concurrent gabapentinoid use. In adjusted models, increasing age and worsening cognition were inversely associated with the concurrent use of both classes, but most other significantly related covariates were unique to each drug class (e.g., sex and anxiety disorders for BZD, pain severity and presence of pain‐related conditions for gabapentinoids).

Conclusions

Co‐administration of BZDs or gabapentinoids in Ontario nursing home residents dispensed opioids remains common, but the pattern of co‐use has changed over time. Observed covariates of concurrent use in 2019/20 suggest distinct but overlapping resident populations requiring consideration of the relative risks versus benefits of this co‐use and monitoring for potential harm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidBenzodiazepinesHumansCross-Sectional StudiesOntarioNursing Homes

Stichwörter der Autor:innen

benzodiazepinesgabapentinoidslong-term carenursing homeopioids

Substanzen

Analgesics, OpioidBenzodiazepines

Autor:innen und Institutionen

  • Department of Medicine, Division of Geriatric Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • ICES, Toronto, Ontario, Canada.
  • Institute of Health Policy, Management & Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, Toronto, Ontario, Canada.
  • Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
  • Toronto Rehabilitation Institute, University Health Network, Toronto, Ontario, Canada.

ORCID-Profile: Susan E Bronskill, Andrea Iaboni, Colleen J Maxwell

Förderung

  • CIHR
  • Canadian Institutes of Health Research
  • Institute for Clinical Evaluative Sciences

Zitieren

APA

Hogan, D. B., Campitelli, M. A., Bronskill, S. E., Iaboni, A., Barry, H. E., Hughes, C. M., Gill, S. S., & Maxwell, C. J. (2023). Trends and correlates of concurrent opioid and benzodiazepine and/or gabapentinoid use among Ontario nursing home residents. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.18320

Vancouver

Hogan DB, Campitelli MA, Bronskill SE, Iaboni A, Barry HE, Hughes CM, et al. Trends and correlates of concurrent opioid and benzodiazepine and/or gabapentinoid use among Ontario nursing home residents. Journal of the American Geriatrics Society. 2023. doi:10.1111/jgs.18320

BibTeX
@article{Hogan2023,
  author = {Hogan, David B and Campitelli, Michael A and Bronskill, Susan E and Iaboni, Andrea and Barry, Heather E and Hughes, Carmel M and Gill, Sudeep S and Maxwell, Colleen J},
  title = {Trends and correlates of concurrent opioid and benzodiazepine and/or gabapentinoid use among Ontario nursing home residents},
  journal = {Journal of the American Geriatrics Society},
  year = {2023},
  doi = {10.1111/jgs.18320}
}
Kostenlos starten →